Literature DB >> 26379905

Metabolomics in bladder cancer: a systematic review.

Yidong Cheng1, Xiao Yang1, Xiaheng Deng1, Xiaolei Zhang1, Pengchao Li1, Jun Tao1, Chao Qin1, Jifu Wei2, Qiang Lu1.   

Abstract

Bladder cancer (BC) is the most common urological malignancy. Early diagnosis of BC is crucial to improve patient outcomes. Currently, metabolomics is a potential technique that can be used to detect BC. We reviewed current publications and synthesised the findings on BC and metabolomics, i.e. metabolite upregulation and downregulation. Fourteen metabolites (lactic acid, leucine, valine, phenylalanine, glutamate, histidine, aspartic acid, tyrosine, serine, uracil, hypoxanthine, carnitine, pyruvic acid and citric acid) were identified as potential biomarkers for BC. In conclusion, this systematic review presents new opportunities for the diagnosis of BC.

Entities:  

Keywords:  Bladder cancer; mass spectrometry; metabolomics; systematic review

Year:  2015        PMID： 26379905      PMCID： PMC4565288     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN： 1940-5901


  57 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Metabolomics in toxicology: preclinical and clinical applications.

Authors:  Donald G Robertson; Paul B Watkins; Michael D Reily
Journal:  Toxicol Sci       Date:  2010-12-02       Impact factor: 4.849

Review 3.  Metabolomics: available results, current research projects in breast cancer, and future applications.

Authors:  Wederson Marcos Claudino; Alessandro Quattrone; Laura Biganzoli; Marta Pestrin; Ivano Bertini; Angelo Di Leo
Journal:  J Clin Oncol       Date:  2007-05-14       Impact factor: 44.544

4.  Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion.

Authors:  J Khasawneh; M D Schulz; A Walch; J Rozman; M Hrabe de Angelis; M Klingenspor; A Buck; M Schwaiger; D Saur; R M Schmid; G Klöppel; B Sipos; F R Greten; M C Arkan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

5.  Clinical report: a patient with primary peritoneal mesothelioma that has improved after taking citric acid orally.

Authors:  A H Bucay
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-02-22       Impact factor: 2.947

Review 6.  Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer.

Authors:  Y Liu
Journal:  Prostate Cancer Prostatic Dis       Date:  2006-05-09       Impact factor: 5.554

Review 7.  Urine markers for bladder cancer surveillance: a systematic review.

Authors:  Bas W G van Rhijn; Henk G van der Poel; Theo H van der Kwast
Journal:  Eur Urol       Date:  2005-03-23       Impact factor: 20.096

8.  NMR-based metabolomic analysis of human bladder cancer.

Authors:  Ming Cao; Liangcai Zhao; Haige Chen; Wei Xue; Donghai Lin
Journal:  Anal Sci       Date:  2012       Impact factor: 2.081

9.  Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

Authors:  Michael I Koukourakis; Alexandra Giatromanolaki; Adrian L Harris; Efthimios Sivridis
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

10.  A serum nuclear magnetic resonance-based metabolomic signature of advanced metastatic human breast cancer.

Authors:  Elodie Jobard; Clément Pontoizeau; Benjamin J Blaise; Thomas Bachelot; Bénédicte Elena-Herrmann; Olivier Trédan
Journal:  Cancer Lett       Date:  2013-09-14       Impact factor: 8.679
View more
  25 in total

Review 1.  Recent advances in the metabolomic study of bladder cancer.

Authors:  Chandra Sekhar Amara; Venkatrao Vantaku; Yair Lotan; Nagireddy Putluri
Journal:  Expert Rev Proteomics       Date:  2019-02-26       Impact factor: 3.940

2.  Perspective: Do Fasting, Caloric Restriction, and Diets Increase Sensitivity to Radiotherapy? A Literature Review.

Authors:  Philippe Icard; Luc Ollivier; Patricia Forgez; Joelle Otz; Marco Alifano; Ludovic Fournel; Mauro Loi; Juliette Thariat
Journal:  Adv Nutr       Date:  2020-09-01       Impact factor: 8.701

3.  Research Progress of Urine Biomarkers in the Diagnosis, Treatment, and Prognosis of Bladder Cancer.

Authors:  Feng Jin; Muhammad Shahid; Jayoung Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  The effect of amino acids on the bladder cycle: a concise review.

Authors:  Özer Ural Çakıcı; Sibel Dinçer
Journal:  Amino Acids       Date:  2021-12-01       Impact factor: 3.520

Review 5.  Cruciferous Vegetables, Isothiocyanates, and Bladder Cancer Prevention.

Authors:  Besma Abbaoui; Christopher R Lucas; Ken M Riedl; Steven K Clinton; Amir Mortazavi
Journal:  Mol Nutr Food Res       Date:  2018-08-29       Impact factor: 5.914

Review 6.  Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.

Authors:  Julieta Afonso; Lúcio L Santos; Adhemar Longatto-Filho; Fátima Baltazar
Journal:  Nat Rev Urol       Date:  2020-01-17       Impact factor: 14.432

7.  The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer.

Authors:  Jing-Zi Wang; Wei Zhu; Jie Han; Xiao Yang; Rui Zhou; Hong-Cheng Lu; Hao Yu; Wen-Bo Yuan; Peng-Chao Li; Jun Tao; Qiang Lu; Ji-Fu Wei; Haiwei Yang
Journal:  Cancer Commun (Lond)       Date:  2021-05-15

Review 8.  Metabolomics: Bridging the Gap between Pharmaceutical Development and Population Health.

Authors:  Vladimir Tolstikov
Journal:  Metabolites       Date:  2016-07-08

9.  Metabolite marker discovery for the detection of bladder cancer by comparative metabolomics.

Authors:  Chi-Hung Shao; Chien-Lun Chen; Jia-You Lin; Chao-Jung Chen; Shu-Hsuan Fu; Yi-Ting Chen; Yu-Sun Chang; Jau-Song Yu; Ke-Hung Tsui; Chiun-Gung Juo; Kun-Pin Wu
Journal:  Oncotarget       Date:  2017-06-13

10.  Subpathway-CorSP: Identification of metabolic subpathways via integrating expression correlations and topological features between metabolites and genes of interest within pathways.

Authors:  Chenchen Feng; Jian Zhang; Xuecang Li; Bo Ai; Junwei Han; Qiuyu Wang; Taiming Wei; Yong Xu; Meng Li; Shang Li; Chao Song; Chunquan Li
Journal:  Sci Rep       Date:  2016-09-14       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.